CNS Pharmaceuticals Inc
NASDAQ:CNSP
Cash Flow Statement
Cash Flow Statement
CNS Pharmaceuticals Inc
| Mar-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||||
| Net Income |
(7)
|
(8)
|
(4)
|
(6)
|
(8)
|
(9)
|
(9)
|
(11)
|
(12)
|
(14)
|
(14)
|
(13)
|
(13)
|
(13)
|
(15)
|
(17)
|
(18)
|
(19)
|
(19)
|
(17)
|
(16)
|
(17)
|
(15)
|
(16)
|
(15)
|
(13)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Other Non-Cash Items |
7
|
7
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
2
|
1
|
2
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
0
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
1
|
1
|
(0)
|
1
|
(1)
|
(2)
|
(0)
|
(0)
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
1
|
(4)
|
(3)
|
(6)
|
(3)
|
|
| Cash from Operating Activities |
(1)
N/A
|
(1)
-130%
|
(4)
-186%
|
(5)
-50%
|
(8)
-51%
|
(8)
-3%
|
(7)
+12%
|
(9)
-20%
|
(11)
-26%
|
(12)
-7%
|
(14)
-15%
|
(13)
+2%
|
(12)
+12%
|
(11)
+2%
|
(11)
+8%
|
(12)
-16%
|
(12)
0%
|
(14)
-13%
|
(14)
-2%
|
(13)
+12%
|
(11)
+14%
|
(14)
-32%
|
(17)
-21%
|
(17)
0%
|
(21)
-22%
|
(16)
+22%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||||
| Capital Expenditures |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
(0)
N/A
|
(0)
-100%
|
(0)
-50%
|
(0)
-33%
|
(0)
+25%
|
(0)
+33%
|
(0)
+50%
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-129%
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-91%
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
2
|
10
|
0
|
10
|
9
|
14
|
15
|
16
|
19
|
5
|
15
|
14
|
11
|
16
|
5
|
8
|
8
|
5
|
9
|
8
|
21
|
23
|
29
|
31
|
19
|
|
| Net Issuance of Debt |
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other |
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
1
|
1
|
1
|
|
| Cash from Financing Activities |
1
N/A
|
1
+100%
|
10
+613%
|
10
+0%
|
10
N/A
|
9
-15%
|
14
+61%
|
14
+2%
|
15
+6%
|
19
+23%
|
5
-76%
|
15
+225%
|
14
-6%
|
10
-26%
|
16
+53%
|
5
-68%
|
8
+54%
|
8
+2%
|
5
-40%
|
8
+77%
|
8
-3%
|
20
+154%
|
23
+14%
|
29
+28%
|
31
+7%
|
19
-39%
|
|
| Change in Cash | |||||||||||||||||||||||||||
| Net Change in Cash |
0
N/A
|
0
+6%
|
7
+3 421%
|
5
-26%
|
2
-56%
|
0
-81%
|
7
+1 556%
|
6
-16%
|
4
-25%
|
7
+65%
|
(9)
N/A
|
1
N/A
|
2
+53%
|
(1)
N/A
|
5
N/A
|
(7)
N/A
|
(5)
+36%
|
(6)
-31%
|
(10)
-55%
|
(4)
+55%
|
(3)
+35%
|
6
N/A
|
6
-2%
|
12
+107%
|
11
-13%
|
3
-73%
|
|
| Free Cash Flow | |||||||||||||||||||||||||||
| Free Cash Flow |
(1)
N/A
|
(1)
-131%
|
(4)
-186%
|
(5)
-50%
|
(8)
-51%
|
(8)
-3%
|
(7)
+12%
|
(9)
-20%
|
(11)
-26%
|
(12)
-7%
|
(14)
-15%
|
(13)
+2%
|
(12)
+12%
|
(12)
+2%
|
(11)
+8%
|
(12)
-16%
|
(12)
0%
|
(14)
-13%
|
(14)
-2%
|
(13)
+12%
|
(11)
+14%
|
(14)
-32%
|
(17)
-21%
|
(17)
0%
|
(21)
-22%
|
(16)
+22%
|
|